Method for reducing biofilm formation
View Patent ↗A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
1. A medical therapeutic method comprising:
providing an ultrasonic debridement instrument having an operative tip and a suction channel;
manipulating said instrument to place said operative tip against a patient's tissues at a preselected surgical site;
during contact of said operative tip with the patient's tissues, generating an ultrasonic standing wave in said instrument, thereby fragmenting necrotic tissue and undesired organic material at said surgical site;
during the generating of said ultrasonic standing wave, disposing a suction inlet at a distal end of said suction channel proximate the surgical site;
during the generating of said ultrasonic standing wave, applying vacuum or negative pressure to said suction channel to remove tissue debris fragmented organic material from said surgical site via said suction inlet;
disposing a suction port on said instrument at a position spaced from said surgical site;
operating an actuator to enable sucking of air through said suction port;
during and/or after the generating of said ultrasonic standing wave and the fragmenting of tissue and material, sucking ambient air from a region about said surgical site through said suction port at said position,
said instrument including a longitudinally shiftable sheath or sleeve, said suction channel being located between said sheath or sleeve and a shaft or horn of said instrument, further comprising shifting said sheath or sleeve in a proximal direction after the applying of vacuum or negative pressure and prior to the sucking of the ambient air through said suction port, a distal tip of said sheath or sleeve defining said suction inlet in a distal position of said sheath or sleeve, said distal tip defining said suction port in a proximal position of said sheath or sleeve.
2. A medical therapeutic method comprising:
providing an ultrasonic debridement instrument having an operative tip and a suction channel;
manipulating said instrument to place said operative tip against a patient's tissues at a preselected surgical site;
during contact of said operative tip with the patient's tissues, generating an ultrasonic standing wave in said instrument, thereby fragmenting necrotic tissue and undesired organic material at said surgical site;
during the generating of said ultrasonic standing wave, disposing a suction inlet at a distal end of said suction channel proximate the surgical site;
during the generating of said ultrasonic standing wave, applying vacuum or negative pressure to said suction channel to remove tissue debris fragmented organic material from said surgical site via said suction inlet;
disposing a suction port at a position spaced from said surgical site;
during and/or after the generating of said ultrasonic standing wave and the fragmenting of tissue and material, sucking ambient air from a region about said surgical site through said suction port at said position;
placing at least one ultrasonic transducer on the patient at least proximate the surgical site after terminating of a debridement process and while the surgical site is free of discernible bacteria; and
after the placing of said transducer and while said transducer is in effective vibration-transmitting contact with the patient, conducting an electrical energization waveform of an ultrasonic frequency to said transducer at least intermittently during a period of approximately one day or longer to at least reduce biofilm formation on the patient at the surgical site and facilitate a healing of the patient's tissue at the surgical site.
3. The method defined in claim 2 wherein said transducer is affixed to a carrier pad, the placing of said transducer on the patient including attaching said pad to the patient.
4. The method defined in claim 2 , further comprising utilizing said instrument at a lower energy setting to pre-condition the tissues at the surgical site for disrupting adherence or starting the formation of biofilm.
5. A medical therapeutic method comprising:
providing an ultrasonic debridement instrument having an operative tip and a suction channel;
manipulating said instrument to place said operative tip against a patient's tissues at a preselected surgical site;
during contact of said operative tip with the patient's tissues, generating an ultrasonic standing wave in said instrument, thereby fragmenting necrotic tissue and undesired organic material at said surgical site;
during the generating of said ultrasonic standing wave, disposing a suction inlet at a distal end of said suction channel proximate the surgical site;
during the generating of said ultrasonic standing wave, applying vacuum or negative pressure to said suction channel to remove tissue debris fragmented organic material from said surgical site via said suction inlet;
placing at least one ultrasonic transducer on the patient at least proximate the surgical site after terminating of a debridement process and while the surgical site is free of discernible bacteria; and
after the placing of said transducer and while said transducer is in effective vibration-transmitting contact with the patient, conducting an electrical energization waveform of an ultrasonic frequency to said transducer at least intermittently during a period of approximately one day or longer to at least reduce biofilm formation on the patient at the surgical site and facilitate a healing of the patient's tissue at the surgical site.
6. The method defined in claim 5 wherein said transducer is affixed to a carrier pad, the placing of said transducer on the patient including attaching said pad to the patient.
7. The method defined in claim 5 , further comprising utilizing said instrument at a lower energy setting to pre-condition the tissues at the surgical site for disrupting adherence or starting the formation of biofilm.